TW200738705A - Novel indolizine derivatives, a method for their preparation, and therapeutic compositions comprising them - Google Patents
Novel indolizine derivatives, a method for their preparation, and therapeutic compositions comprising themInfo
- Publication number
- TW200738705A TW200738705A TW095143038A TW95143038A TW200738705A TW 200738705 A TW200738705 A TW 200738705A TW 095143038 A TW095143038 A TW 095143038A TW 95143038 A TW95143038 A TW 95143038A TW 200738705 A TW200738705 A TW 200738705A
- Authority
- TW
- Taiwan
- Prior art keywords
- radical
- alkyl radical
- cyclic
- branched
- linear
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
Indolizine derivatives with general formula (I) in which: X represents a -(CH2)n- radical where n is a whole number from 1 to 6, or a group with formula CH2-Z-(CH2)2-, in which Z represents an -O(CH2)m- group in which m is a whole number from 0 to 3; R1 represents a linear, branched or cyclic C1-C8 alkyl radical; Am represents an NR3R4 group in which R3 and R4 are identical or different and independently of each other represent: - a hydrogen atom; - a linear, branched or cyclic C1-C6 alkyl radical or a C1-C3 radical substituted with a C3-C6 cycloalkyl radical; - or a (CH2)1-O-B radical in which B represents a hydrogen atom or a (CH2)k alkyl radical, where 1 and k are whole numbers, 1≥2and1+k=6; or R3 and R4 together with the nitrogen atom to which they are attached form a heterocycle containing 4 to 6 links which may optionally contain one or more heteroatoms selected from N and O and optionally carrying one or more substituents selected from a linear, branched or cyclic C1-C6 alkyl radical; R2 represents a hydrogen atom or a linear, branched or cyclic C1-C6 alkyl radical; and their pharmaceutically acceptable salts.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0511849A FR2893616B1 (en) | 2005-11-23 | 2005-11-23 | NOVEL INDOLIZINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THERAPEUTIC COMPOSITIONS COMPRISING SAME |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TW200738705A true TW200738705A (en) | 2007-10-16 |
Family
ID=37027751
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW095143038A TW200738705A (en) | 2005-11-23 | 2006-11-21 | Novel indolizine derivatives, a method for their preparation, and therapeutic compositions comprising them |
Country Status (34)
| Country | Link |
|---|---|
| US (1) | US7799799B2 (en) |
| EP (1) | EP1957490B1 (en) |
| JP (1) | JP5372514B2 (en) |
| KR (1) | KR101419066B1 (en) |
| CN (1) | CN101312973B (en) |
| AR (1) | AR058208A1 (en) |
| AT (1) | ATE454386T1 (en) |
| AU (1) | AU2006316381B2 (en) |
| BR (1) | BRPI0618975A2 (en) |
| CA (1) | CA2629738C (en) |
| CR (1) | CR9927A (en) |
| CY (1) | CY1110623T1 (en) |
| DE (1) | DE602006011649D1 (en) |
| DK (1) | DK1957490T3 (en) |
| DO (1) | DOP2006000254A (en) |
| EA (1) | EA014158B1 (en) |
| EC (1) | ECSP088455A (en) |
| ES (1) | ES2338922T3 (en) |
| FR (1) | FR2893616B1 (en) |
| GT (1) | GT200600489A (en) |
| HK (1) | HK1126198A1 (en) |
| HR (1) | HRP20100158T1 (en) |
| IL (1) | IL190861A (en) |
| MA (1) | MA30055B1 (en) |
| NO (1) | NO20082589L (en) |
| PE (1) | PE20071083A1 (en) |
| PL (1) | PL1957490T3 (en) |
| PT (1) | PT1957490E (en) |
| SI (1) | SI1957490T1 (en) |
| TN (1) | TNSN08162A1 (en) |
| TW (1) | TW200738705A (en) |
| UY (1) | UY29965A1 (en) |
| WO (1) | WO2007060318A1 (en) |
| ZA (1) | ZA200803565B (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2893616B1 (en) | 2005-11-23 | 2008-01-04 | Sanofi Aventis Sa | NOVEL INDOLIZINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THERAPEUTIC COMPOSITIONS COMPRISING SAME |
| FR2962438B1 (en) | 2010-07-06 | 2012-08-17 | Sanofi Aventis | INDOLIZINE DERIVATIVES, PREPARATION METHODS AND THERAPEUTIC APPLICATION |
| FR2962437B1 (en) | 2010-07-06 | 2012-08-17 | Sanofi Aventis | IMIDAZOPYRIDINE DERIVATIVES, PROCESS FOR PREPARING THEM AND THEIR THERAPEUTIC APPLICATION |
| CN103360390B (en) * | 2013-07-23 | 2015-06-17 | 东南大学 | Pyrrocoline formylmethyl p-methane sulfonamide phenylethylamine derivative and its medical application |
| CN110156776A (en) * | 2019-04-30 | 2019-08-23 | 贵州省中国科学院天然产物化学重点实验室(贵州医科大学天然产物化学重点实验室) | A kind of preparation method of C-3 sweet-smelling formacyl indolizine class compound |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI61030C (en) * | 1976-02-19 | 1982-05-10 | Sanofi Sa | FRAMEWORK FOR THERAPEUTIC TREATMENT OF THERAPEUTIC NETWORK 2-SUBSTITUTES-1-ELLER 3-BENZOYL-INDOLIZERDERIVAT |
| FR2665444B1 (en) * | 1990-08-06 | 1992-11-27 | Sanofi Sa | AMINO-BENZOFURAN, BENZOTHIOPHENE OR INDOLE DERIVATIVES, THEIR PREPARATION PROCESS AND THE COMPOSITIONS CONTAINING THEM. |
| US5334716A (en) * | 1991-06-17 | 1994-08-02 | Fujisawa Pharmaceutical Co., Ltd. | Heterocyclic derivatives |
| US6593322B1 (en) * | 1999-03-17 | 2003-07-15 | Signal Pharmaceuticals, Inc. | Compounds and methods for modulation of estrogen receptors |
| FR2813306B1 (en) * | 2000-08-23 | 2005-10-21 | Sanofi Synthelabo | AMINOALKYBENZOYL-BENZOFURANS OR BENZOTHIOPHENES, PROCESS FOR THEIR PREPARATION AND COMPOSITIONS CONTAINING SAME |
| FR2893616B1 (en) | 2005-11-23 | 2008-01-04 | Sanofi Aventis Sa | NOVEL INDOLIZINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THERAPEUTIC COMPOSITIONS COMPRISING SAME |
-
2005
- 2005-11-23 FR FR0511849A patent/FR2893616B1/en not_active Expired - Fee Related
-
2006
- 2006-11-15 DO DO2006000254A patent/DOP2006000254A/en unknown
- 2006-11-20 PE PE2006001477A patent/PE20071083A1/en not_active Application Discontinuation
- 2006-11-20 GT GT200600489A patent/GT200600489A/en unknown
- 2006-11-21 EA EA200801400A patent/EA014158B1/en not_active IP Right Cessation
- 2006-11-21 AU AU2006316381A patent/AU2006316381B2/en not_active Ceased
- 2006-11-21 AR ARP060105086A patent/AR058208A1/en not_active Application Discontinuation
- 2006-11-21 DE DE602006011649T patent/DE602006011649D1/en active Active
- 2006-11-21 EP EP06831144A patent/EP1957490B1/en active Active
- 2006-11-21 ZA ZA200803565A patent/ZA200803565B/en unknown
- 2006-11-21 WO PCT/FR2006/002551 patent/WO2007060318A1/en active Application Filing
- 2006-11-21 AT AT06831144T patent/ATE454386T1/en active
- 2006-11-21 PL PL06831144T patent/PL1957490T3/en unknown
- 2006-11-21 PT PT06831144T patent/PT1957490E/en unknown
- 2006-11-21 CN CN2006800437271A patent/CN101312973B/en not_active Expired - Fee Related
- 2006-11-21 JP JP2008541787A patent/JP5372514B2/en not_active Expired - Fee Related
- 2006-11-21 TW TW095143038A patent/TW200738705A/en unknown
- 2006-11-21 CA CA2629738A patent/CA2629738C/en not_active Expired - Fee Related
- 2006-11-21 DK DK06831144.8T patent/DK1957490T3/en active
- 2006-11-21 BR BRPI0618975-0A patent/BRPI0618975A2/en not_active IP Right Cessation
- 2006-11-21 ES ES06831144T patent/ES2338922T3/en active Active
- 2006-11-21 SI SI200630601T patent/SI1957490T1/en unknown
- 2006-11-21 KR KR1020087012214A patent/KR101419066B1/en not_active IP Right Cessation
- 2006-11-23 UY UY29965A patent/UY29965A1/en unknown
-
2008
- 2008-04-10 TN TNP2008000162A patent/TNSN08162A1/en unknown
- 2008-04-14 IL IL190861A patent/IL190861A/en not_active IP Right Cessation
- 2008-04-25 CR CR9927A patent/CR9927A/en not_active Application Discontinuation
- 2008-05-08 US US12/116,996 patent/US7799799B2/en not_active Expired - Fee Related
- 2008-05-16 EC EC2008008455A patent/ECSP088455A/en unknown
- 2008-06-10 NO NO20082589A patent/NO20082589L/en not_active Application Discontinuation
- 2008-06-16 MA MA31037A patent/MA30055B1/en unknown
-
2009
- 2009-05-19 HK HK09104558.7A patent/HK1126198A1/en not_active IP Right Cessation
-
2010
- 2010-03-18 HR HR20100158T patent/HRP20100158T1/en unknown
- 2010-03-31 CY CY20101100303T patent/CY1110623T1/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0301607A2 (en) | Heterocyclic compound containing nitrogen atoms having selective neurokinin anatgonist effect pharmaceutical compositions containing them and their use | |
| MY145603A (en) | 2-ARYL-6-PHENYLIMIDAZO[1,2-a]PYRIDINE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF | |
| TW200738705A (en) | Novel indolizine derivatives, a method for their preparation, and therapeutic compositions comprising them | |
| NO20082975L (en) | Novel cyclic urea derivatives, their preparation and their pharmaceutical use as kinase inhibitors | |
| NO20054224L (en) | New 2-pyridinecarboxamide derivatives | |
| GEP20125581B (en) | Sulfonyl amide derivatives for treatment of abnormal cell growth | |
| HUP0303183A2 (en) | Heterocyclic diamide invertebrate pest control agents, compositions containing them and use thereof | |
| TW200612920A (en) | Novel imidazolidine derivatives | |
| TW200732284A (en) | Amine compound and pharmaceutical use thereof | |
| UA100003C2 (en) | 1,2,4,5-tetrahydro-3h-benzazepine compounds, a process for their preparation and pharmaceutical compositions containing them | |
| NO20061789L (en) | Aminopyridine derivatives as inducible NO synthase inhibitors | |
| TW200609220A (en) | Tetrahydroisoquinolylsulphonamide derivatives, their preparation and their use in therapeutics | |
| MX2009010837A (en) | Nitrogenous heterocyclic compounds, preparation thereof and use thereof as antibacterial medicaments. | |
| SE9701304D0 (en) | Compounds | |
| TW200616997A (en) | The preparation method for 6-substituted-1-methyl-1h-benzoimidazol derivatives and their preparation imtermediates | |
| NO20052598L (en) | New 2,3-dihydro-4 (1H) -pyridone compounds, processes for their preparation, and pharmaceutical compositions containing them. | |
| NO20055749L (en) | Sulfamate benzothiophene derivatives as steroid sulfatase inhibitors | |
| HUP0203275A2 (en) | 1-cyclic amino-alkylcyclohexane compounds, pharmaceutical compositions thereof, and their use as anticonvulsants | |
| EP1400515A4 (en) | Cyclic diamine compound having five-membered cyclic group | |
| HUP0301000A2 (en) | 2-aminothiazoline derivatives and their use as no-synthase inhibitors, process for their preparation and pharmaceutical compositions containing them | |
| HUP0303127A2 (en) | Novel lipoic acid heterocyclic or benzene derivatives, preparation and use thereof as medicines | |
| HUP0204217A2 (en) | Novel a-500359 derivatives | |
| EA201000666A1 (en) | DERIVATIVES OF 5-SUBSTITUTED INDOL-3-CARBIC ACID, possessing antiviral activity, method of their production and use | |
| HUP0100564A2 (en) | Matrix metalloproteinase inhibitors and pharmaceuticals comprising them | |
| NZ504298A (en) | 2,3-methano-amino acid compounds for treating serine protease disorders |